The clinical determinants of fibrosis progression in nonalcoholic fatty liver disease (NAFLD) are still under definition.
Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease
ROSSO, CHIARA;BUGIANESI, Elisabetta;
2016-01-01
Abstract
The clinical determinants of fibrosis progression in nonalcoholic fatty liver disease (NAFLD) are still under definition.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Pelusi S_journal.pone.0163069.pdf
Accesso aperto
Tipo di file:
PDF EDITORIALE
Dimensione
816.2 kB
Formato
Adobe PDF
|
816.2 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
